Pre-Clinical and Clinical Studies on Hirulog: A Potent and Specific Direct Thrombin Inhibitor
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 340, 227-236
- https://doi.org/10.1007/978-1-4899-2418-6_20
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- COFACTOR PROTEINS IN THE ASSEMBLY AND EXPRESSION OF BLOOD CLOTTING ENZYME COMPLEXESAnnual Review of Biochemistry, 1988
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Human .alpha.-thrombin binding to nonpolymerized fibrin-sepharose: evidence for an anionic binding regionBiochemistry, 1985
- Experimental Arterial Thromboembolism in BaboonsJournal of Clinical Investigation, 1979
- The action of thrombin on blood clotting factor V: conversion of factor V to a prothrombin-binding proteinBiochimica et Biophysica Acta (BBA) - Protein Structure, 1973